Costanzo A - Search Results

1

Effectiveness End Points in Real-World Studies on Biological Therapies in Psoriasis: Systematic Review with Focus on Drug Survival.

Costanzo A, Malara G, Pelucchi C, Fatiga F, Barbera G, Franchi A, Galeone C. Costanzo A, et al. Dermatology. 2018;234(1-2):1-12. doi: 10.1159/000488586. Epub 2018 May 15. Dermatology. 2018. PMID: 30300876

2

Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers.

Costanzo A, Talamonti M, Botti E, Spallone G, Papoutsaki M, Chimenti S. Costanzo A, et al. Dermatology. 2009;219(1):48-53. doi: 10.1159/000213758. Epub 2009 Apr 16. Dermatology. 2009. PMID: 19372639

3

The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab.

Papoutsaki M, Talamonti M, Giunta A, Costanzo A, Ruzzetti M, Teoli M, Chimenti S. Papoutsaki M, et al. Among authors: costanzo a. Dermatology. 2010;221 Suppl 1:43-7. doi: 10.1159/000316184. Epub 2010 Aug 9. Dermatology. 2010. PMID: 20733314

4

Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension.

Talamonti M, Teoli M, Botti E, Spallone G, Chimenti S, Costanzo A. Talamonti M, et al. Among authors: costanzo a. Dermatology. 2011;222(3):250-5. doi: 10.1159/000326111. Epub 2011 Apr 13. Dermatology. 2011. PMID: 21494026

5

What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practice.

Talamonti M, Galluzzo M, Bianchi L, Boca AN, Costanzo A, Chimenti S. Talamonti M, et al. Among authors: costanzo a. Dermatology. 2014;229(4):324-32. doi: 10.1159/000365077. Epub 2014 Nov 15. Dermatology. 2014. PMID: 25402662

6

IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.

Galluzzo M, Boca AN, Botti E, Potenza C, Malara G, Malagoli P, Vesa S, Chimenti S, Buzoianu AD, Talamonti M, Costanzo A. Galluzzo M, et al. Among authors: costanzo a. Dermatology. 2016;232(2):230-6. doi: 10.1159/000441719. Epub 2015 Dec 18. Dermatology. 2016. PMID: 26678060

7

Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients.

Talamonti M, Galluzzo M, van den Reek JM, de Jong EM, Lambert JLW, Malagoli P, Bianchi L, Costanzo A. Talamonti M, et al. Among authors: costanzo a. Br J Dermatol. 2017 Aug;177(2):489-496. doi: 10.1111/bjd.15387. Epub 2017 Jun 22. Br J Dermatol. 2017. PMID: 28207934

8

Papp K, Bachelez H, Costanzo A, Foley P, Gooderham M, Kaur P, Philipp S, Spelman L, Zhang N, Strober B. Papp K, et al. Among authors: costanzo a. Br J Dermatol. 2017 Dec;177(6):1562-1574. doi: 10.1111/bjd.15857. Epub 2017 Dec 1. Br J Dermatol. 2017. PMID: 28755394 Clinical Trial.

9

Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.

Potenza MC, Peris K, Berardesca E, Bianchi L, Richetta A, Bernardini N, De Simone C, Teoli M, Zangrilli A, D'epiro S, Orsini D, Narcisi A, Chimenti S, Costanzo A. Potenza MC, et al. Among authors: costanzo a. Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12565. Epub 2017 Dec 7. Dermatol Ther. 2018. PMID: 29215183

10

HLA-C*06 and psoriasis: susceptibility, phenotype, course and response to treatment.

Borroni RG, Costanzo A. Borroni RG, et al. Among authors: costanzo a. Br J Dermatol. 2018 Apr;178(4):825. doi: 10.1111/bjd.16412. Br J Dermatol. 2018. PMID: 29668091 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

846 results

Search Page

Filters